Decline in serum progastrin-releasing peptide predicts the response of patients with small cell lung cancer to chemotherapy

The utility of serum progastrin-releasing peptide (ProGRP) and neuron-specific enolase (NSE) as biomarkers for treatment monitoring and as prognostic factors was investigated in small cell lung cancer (SCLC) patients. Patients were first diagnosed pathologically at the First Affiliated Hospital of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ming, Han, Dandan, Wang, Wei, Zhang, Yang, Li, Dan, Dai, Chunyang, Qian, Liting, Lin, Wenchu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577081/
https://www.ncbi.nlm.nih.gov/pubmed/33101495
http://dx.doi.org/10.3892/ol.2020.12164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577081/
https://www.ncbi.nlm.nih.gov/pubmed/33101495
http://dx.doi.org/10.3892/ol.2020.12164

Ejemplares similares